Comprehensive bioinformatics analysis reveals key hub genes linked to prognosis in multiple myeloma with drug resistance.

Multiple myeloma (MM) is an incurable hematologic malignancy, with chemotherapy being the primary treatment. However, the development of drug resistance remains a major challenge. This study aimed to identify therapeutic targets associated with drug resistance in MM and assess their prognostic significance.